Norman, Robert J.

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersGenetic and Kidney Cyst Diseases

Cited by 2,143

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 2,132

Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 1,976

Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome

Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & the International PCOS Network (2018) · Clinical Endocrinology

Ovarian function and disordersClinical practice guidelines implementation

Cited by 1,823

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

March, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 1,799

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome

Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., International PCOS Network, Andersen, M., et al. (2018) · Human Reproduction

Ovarian function and disordersClinical practice guidelines implementation

Cited by 1,593

Polycystic ovary syndrome

Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,360

Recommendations from the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., Andersen, M., Azziz, R., et al. (2018) · Fertility and Sterility

Ovarian function and disordersClinical practice guidelines implementation

Cited by 1,325

Impaired Glucose Tolerance, Type 2 Diabetes and Metabolic Syndrome in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,108

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,010

Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

Teede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersClinical practice guidelines implementation

Cited by 946

Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis

Lim, S. S., Davies, M. J., Norman, R. J., & Moran, L. J. (2012) · Human Reproduction Update

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 939

Polycystic ovary syndrome

Joham, A. E., Norman, R. J., Stener-Victorin, E., Legro, R. S., Franks, S., Moran, L. J., Boyle, J., & Teede, H. J. (2022) · The Lancet Diabetes & Endocrinology

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 838

Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment

Clark, A. M., Thornley, B., Tomlinson, L., Galletley, C., & Norman, R. J. (1998) · Human Reproduction

Ovarian function and disordersReproductive Health and Technologies

Cited by 789

The management of anovulatory infertility in women with polycystic ovary syndrome: An analysis of the evidence to support the development of global who guidance

Balen, A. H., Morley, L. C., Misso, M., Franks, S., Legro, R. S., Wijeyaratne, C. N., Stener-Victorin, E., Fauser, B. C. J. M., Norman, R. J., & Teede, H. (2016) · Human Reproduction Update

Ovarian function and disordersReproductive Health and Technologies

Cited by 705

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

Tang, T., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2012) · Cochrane Database of Systematic Reviews

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 698

Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women

Clark, A. M., Ledger, W., Galletly, C., Tomlinson, L., Blaney, F., Wang, X., & Norman, R. J. (1995) · Human Reproduction

Ovarian function and disordersReproductive Health and Technologies

Cited by 642

A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China

Qiao, J., Wang, Y., Li, X., Jiang, F., Zhang, Y., Ma, J., Song, Y., Ma, J., Fu, W., Pang, R., et al. (2021) · The Lancet

Global Maternal and Child HealthMaternal and Neonatal Healthcare

Cited by 569

Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society

Dewailly, D., Lujan, M. E., Carmina, E., Cedars, M. I., Laven, J., Norman, R. J., & Escobar-Morreale, H. F. (2014) · Human Reproduction Update

Ovarian function and disordersGenetic and Kidney Cyst Diseases

Cited by 551

The impact of lifestyle factors on reproductive performance in the general population and those undergoing infertility treatment: a review

Homan, G. F., Davies, M., & Norman, R. (2007) · Human Reproduction Update

Reproductive Health and TechnologiesOvarian function and disorders

Cited by 546

The effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysis

Lim, S. S., Norman, R. J., Davies, M. J., & Moran, L. J. (2013) · Obesity Reviews

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 539

Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome

Moran, L. J., Noakes, M., Clifton, P. M., Tomlinson, L., & Norman, R. J. (2003) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 530

Polycystic ovary syndrome

Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024) · Nature Reviews Disease Primers

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 495

Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society

Escobar-Morreale, H. F., Carmina, E., Dewailly, D., Gambineri, A., Kelestimur, F., Moghetti, P., Pugeat, M., Qiao, J., Wijeyaratne, C. N., Witchel, S. F., et al. (2012) · Human Reproduction Update

Ovarian function and disordersAdrenal Hormones and Disorders

Cited by 494